$SI SEC Filings

Filed On	Filing
08 Oct 2026	8-K: Regulation FD Disclosure Limited User Release of the Company’s Next-Generation InSet® Glenoid Implant Follows Successful Completion of First Surgical Case
06 Oct 2026	Form 4: Sidow Kevin K., Director Received 892 shares as a grant or award ($17.5K)
06 Oct 2026	Form 4: Hykes Andrew, Director Received 669 shares as a grant or award ($13.1K)
06 Oct 2026	Form 4: Tansey Casey M, Director Received 733 shares as a grant or award ($14.4K)
06 Oct 2026	Form 4: Buckman Paul, Director Received 1,275 shares as a grant or award ($25K)
14 Sep 2026	Form 4: Ball Robert Joseph, Director Received 89,233 shares by exercise or conversion ($187K) · Sold 10,175 shares ($188K)
14 Sep 2026	144
28 Aug 2026	Form 4: Gilde Healthcare Holding B.v., 10% owner Sold 1,196 shares ($27K)
24 Aug 2026	Form 4: Gilde Healthcare Holding B.v., 10% owner Sold 3,900 shares ($88.1K) · Sold 20,516 shares ($464K) · Sold 681 shares ($15.4K)
18 Aug 2026	Form 4: Ahearn Matthew Fraser, Director Gave 2,500 shares as a gift · Sold 8,314 shares ($167K) · Sold 14,186 shares ($298K)
17 Aug 2026	144
13 Aug 2026	EFFECT
10 Aug 2026	Form 3: Osborne Jonathan E., Chief Commercial Officer Holds 60,355 shares of Common Stock
10 Aug 2026	8-K: Regulation FD Disclosure
07 Aug 2026	SCHEDULE 13D/A
07 Aug 2026	Form 4: Gilde Healthcare Holding B.v., 10% owner Sold 7,338 shares ($166K) · Sold 2,095 shares ($47.3K)
07 Aug 2026	S-3
06 Aug 2026	10-Q
06 Aug 2026	SCHEDULE 13G/A
06 Aug 2026	8-K: Results of Operations and Financial Condition

Comments